P53 dependent apoptosis-associated gene and protein

Details P53 dependent apoptosis-associated gene and protein P53 dependent apoptosis-associated gene and protein

2001-08-02

2009-08-04

Prouty, Rebecca E (Department: 1656)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C536S023500, C536S023100, C435S252300, C435S254110, C435S254200, C435S320100, C435S325000, C435S419000, C435S069100, C435S070100, C435S071100, C435S004000, C530S300000, C530S350000, C530S395000

Reexamination Certificate

active

07569351

ABSTRACT:
A novel apoptosis-associated gene p53AIPI is isolated by screening for a gene the expression of which is induced by p53. Since the protein encoded by this gene has an activity of inducing apoptosis, this gene is useful in developing effective therapeutic agents for cancer mediated by apoptosis. A method of screening for a compound controlling the induction of apoptosis which is expected as being useful in developing an apoptosis controlling agent.

REFERENCES:
patent: 5789201 (1998-08-01), Guastella
patent: 6083735 (2000-07-01), Yuan et al.
patent: 6087160 (2000-07-01), Yuan et al.
patent: 6214572 (2001-04-01), Yuan et al.
patent: 6416753 (2002-07-01), Yuan et al.
patent: 6812339 (2004-11-01), Venter et al.
patent: 2002/0132767 (2002-09-01), Rosen et al.
patent: 2003/0049709 (2003-03-01), Yuan et al.
patent: 2004/0033502 (2004-02-01), Williams et al.
patent: 2000-83672 (2000-03-01), None
patent: 2000-210089 (2000-08-01), None
patent: WO 96/12017 (1996-04-01), None
patent: WO 98/42835 (1998-10-01), None
patent: WO 99/52925 (1998-10-01), None
patent: WO 98/57664 (1998-12-01), None
Gomez-Manzano, C. et al “Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis” Cancer Research (1996) 56:694-699.
Witkowski et al., Biochemistry, vol. 38, pp. 11643-11650, 1999.
Dang et al., Clin. Cancer Res., vol. 5, pp. 471-474, 1999.
King et al., Annu. Rev. Physiol., vol. 60, pp. 601-617, 1998.
Brown, T., “Current Protocols in Molecular Biology”(Unit 2.9A) pp. 1-2 and (Unit 2.10), pp. 1-16, 1993.
Fox, J., Nat. Biotechnol., vol. 21, p. 217, 2003.
Attardi, L.D., et al., “PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family,”Genes&Develop.14:704-718, Cold Spring Harbor Laboratory Press (Mar. 2000).
Kroemer, G., “The proto-oncogene Bcl-2 and its role in regulating apoptosis,”Nat. Med.3:614-620, Nature Publishing Group (1997).
Lacanà, E., et al., “Dissociation of Apoptosis and Activation of IL-1β-Converting Enzyme/Ced-3 Proteases byALG-2and the Truncated Alzheimer's GeneALG-3,” J. Immunol.158:5129-5135, American Association of Immunologists (1997).
Miyashita, T. and Reed, J.C., “Tumor Suppressor p53 Is a Direct Transcriptional Activator of the HumanbaxGene,” Cell 80:293-299, Cell Press (1995).
Müller, M., et al., “p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs,”J. Exp. Med.188:2033-2045, The Rockefeller University Press (1998).
Nakano, K. and Vousden, K.H., “PUMA,a Novel Proapoptotic Gene, Is Induced by p53,” Mol. Cell 7:683-694, Cell Press (Mar. 2001).
Oda, E., et al., “Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis,”Science288:1053-1058, American Association for the Advancement of Science (May 2000).
Oda, K., et al., “p53AIP1, a Potential Mediator of p53-Dependent Apoptosis, and Its Regulation by Ser-46-Phosphorylated p53,”Cell102:849-862, Cell Press (Sep. 2000).
Polyak, K., et al., “A model for p53-induced apoptosis,”Nature389:300-305, Nature Publishing Group (1997).
Resnick-Silverman, L., et al., “Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53,”Genes&Develop.12:2102-2107, Cold Spring Harbor Laboratory Press (1998).
Ryan, K.M. and Vousden, K.H., “Charactization of Structural p53 Mutants Which Show Selective Defects in Apoptosis but Not Cell Cycle Arrest,”Mol. Cell. Biol.18:3692-3698, American Society for Microbiology (1998).
Saller, E., et al., “Increased apoptosis induction by 121F mutant p53,”EMBO J.18:4424-4437, Oxford University Press (Aug. 16, 1999).
Tanaka, H., et al., “A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage,”Nature404:42-49, Nature Publishing Group (Mar. 2000).
Tokino, T., et al., “p53 tagged sites from human genomic DNA,”Human Mol. Genet.3:1537-1542, Oxford University Press (1994).
Vito, P., et al., “Interfering with Apoptosis: Ca2 +-Binding Protein ALG-2 and Alzheimer's Disease Gene ALG-3,”Science271:521-525, American Association for the Advancement of Science (1996).
Yu, J., et al., “PUMA Induces the Rapid Apoptosis of Colorectal Cancer Cells,”Mol. Cell.7:673-682, Cell Press (Mar. 2001).
International Search Report for International Patent Application No. PCT/JP01/06666, mailed Nov. 6, 2001.
Dialog File 351, Accession No. 10725049, Derwent English language abstract for WO 96/12017 (Document AL1).
Dialog File 351, Accession No. 12115094, Derwent English language abstract for WO 98/42835 (Document AM1).
Patent Abstracts of Japan, English language abstract for JP2000-083672 (Document AP1).
Patent Abstracts of Japan, English language abstract for JP2000-210089 (Document AL2).

Affiliated with

Also associated with

Rating

P53 dependent apoptosis-associated gene and protein does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with P53 dependent apoptosis-associated gene and protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and P53 dependent apoptosis-associated gene and protein will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4070426